Mechanistic insights into chloride-related heart failure progression according to the plasma volume status.
Body fluid
Chloride
Heart failure
Pathophysiology
Vascular volume
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
04
03
2022
received:
20
12
2021
accepted:
28
03
2022
pubmed:
7
4
2022
medline:
6
5
2022
entrez:
6
4
2022
Statut:
ppublish
Résumé
Two types of heart failure (HF) progression were recently proposed on the basis of an increased vs. non-increased serum chloride concentration. The applicability of this concept to real-world HF pathophysiology requires further investigation. The present study evaluated the mechanisms of HF progression to a different type according to changes in the estimated plasma volume status (ePVS). Data from 47 patients (32% men; 78.2 ± 9.7 years of age) with stable to worsening HF (37.5 ± 16 days) were analysed. Physical examination, standard blood tests, and b-type natriuretic peptide (BNP) measurements were conducted. The ePVS was calculated as follows: ePVS (dL/g) = [100 - haematocrit (%)]/[haemoglobin (g/dL)]. For the study subjects as a whole (n = 47), changes in the ePVS correlated positively with changes in the serum chloride concentration from stable to worsening HF (r = 0.398, P = 0.0056). When divided into two groups of worsening HF with an increased (n = 31) vs. non-increased serum chloride concentration (n = 16), no significant baseline differences in body weight, serum logBNP, or ePVS were detected between groups. Under worsening HF, the increase in body weight (2.34 ± 1.12 vs. 2.59 ± 1.56 kg, P = 0.57) and logBNP (0.39 ± 0.30 vs. 0.54 ± 0.31 pg/mL, P = 0.13) did not differ between groups, but the increase in the ePVS was smaller in the group with a non-increased serum chloride concentration compared with that with an increased serum chloride concentration (0.292 ± 0.49 vs. 0.653 ± 0.60 dL/g, P = 0.044). An increase in the %change in ePVS ≥ 10% was less common in patients with a non-increased chloride concentration (37% vs. 71%, P = 0.03). Patients with a non-increased serum chloride concentration had more HF signs (3.31 ± 0.79 vs. 2.65 ± 0.71, P = 0.005) and a higher incidence of pulmonary rales (63% vs. 16%, P = 0.0024) than those with an increased serum chloride concentration. According to the changes in the ePVS, HF progression may result from a difference between two HF types (i.e. increased vs. non-increased serum chloride concentration) in the cardiac reserve in response to a given cardiac burden by modulating plasma volume status via the possible tonicity potential of chloride.
Identifiants
pubmed: 35384366
doi: 10.1002/ehf2.13927
pmc: PMC9065841
doi:
Substances chimiques
Chlorides
0
Hemoglobins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2044-2048Informations de copyright
© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Cardiol Ther. 2020 Dec;9(2):227-244
pubmed: 32378135
Eur J Heart Fail. 2017 Feb;19(2):226-236
pubmed: 27758007
Cardiol Ther. 2021 Dec;10(2):407-428
pubmed: 34398440
J Am Coll Cardiol. 2013 Aug 6;62(6):516-24
pubmed: 23747773
Clin Res Cardiol. 2019 May;108(5):563-573
pubmed: 30370469
Med Hypotheses. 2017 Jul;104:170-173
pubmed: 28673579
Eur J Heart Fail. 2015 Jul;17(7):689-96
pubmed: 25924078
Int J Cardiol. 2017 Mar 1;230:556-561
pubmed: 28062134
Cardiol Ther. 2020 Dec;9(2):333-347
pubmed: 32772346
Eur J Heart Fail. 2014 Feb;16(2):133-42
pubmed: 24464967
J Card Fail. 2019 Apr;25(4):240-248
pubmed: 30528705
JACC Heart Fail. 2015 Nov;3(11):886-93
pubmed: 26541787
Eur J Heart Fail. 2018 Oct;20(10):1426-1435
pubmed: 29943886
ESC Heart Fail. 2015 Dec;2(4):106-115
pubmed: 28834618
J Card Fail. 2019 Mar;25(3):213-217
pubmed: 30296584
Circulation. 1954 May;9(5):706-18
pubmed: 13161102
ESC Heart Fail. 2022 Jun;9(3):2044-2048
pubmed: 35384366
J Am Soc Nephrol. 2007 Jul;18(7):2028-31
pubmed: 17568020
ESC Heart Fail. 2017 Nov;4(4):623-631
pubmed: 29154432